药物依赖性药物对西澳大利亚2003至2018年新生儿戒断综合征发病率的贡献
该研究基于西澳大利亚2003至2018年活产新生儿队列,分析新生儿戒断综合征(NAS)发病率及药物依赖性药物(PDD)的贡献。结果显示NAS总发病率稳定在3.8/1000活产,41.4%的NAS母亲被配发PDD,其中治疗阿片使用障碍的PDD贡献最大(35.2%),但相关NAS逐年下降,而治疗疼痛的阿片类PDD贡献5.2%且保持稳定。
要点
- NAS总发病率研究期间稳定,为3.8/1000活产。
- 治疗阿片使用障碍的PDD是NAS主要驱动因素,但相关NAS下降。
- 治疗疼痛的阿片类PDD贡献5.2%的NAS且保持稳定。
核心结论
- 西澳大利亚2003至2018年NAS发病率保持稳定。
- 治疗阿片使用障碍的药物是NAS的重要驱动因素,但相关NAS随时间下降。
研究设计与样本
- 基于人群的出生队列研究,纳入2003至2018年西澳大利亚所有活产新生儿。
主要发现
- NAS发病率为每1000活产3.8例,年度百分比变化(APC)为0.6(95%CI:-1.3,2.6),无显著变化。
- 41.4%的NAS新生儿母亲被配发PDD。
- 治疗阿片使用障碍的PDD最常被处方,贡献35.2%的NAS病例。
- 治疗疼痛的阿片类PDD贡献5.2%的NAS病例。
- 非阿片类PDD贡献1.7%的NAS病例。
关键数值与推荐
- 与治疗阿片使用障碍的阿片类相关的NAS发病率下降,APC为-6.5(95%CI:-9.5,-3.4)。
- 与治疗疼痛的阿片类相关的NAS发病率保持稳定,APC为-2.7(95%CI:-7.1,1.9)。
临床怎么用
- 临床药学智能体应关注育龄期女性及孕妇使用PDD(尤其是阿片类)的情况,评估新生儿NAS风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: The aim of this study was to examine the incidence of neonatal abstinence syndrome (NAS) in Western Australia (WA) and estimate the contribution of pharmaceutical drugs of dependence (PDD) to NAS. DESIGN: A population-based birth cohort study. DATA SOURCE: Neonates were identified through the Midwives Notification Scheme. Linked medication dispensing and hospital records were used to identify exposure to PDD and NAS diagnosis. PATIENTS: All live born neonates born in WA between 2003 and 2018. MEASUREMENTS: The incidence of NAS and percentage of NAS diagnoses associated with exposure to PDD. MAIN RESULTS: During the study period, the incidence of NAS did not significantly change (annual percentage change (APC): 0.6, 95%CI: -1.3, 2.6), with 3.8 neonates per 1,000 live births diagnosed with NAS. PDD were dispensed to 41.4% of mothers of neonates with NAS, with PDD used to treat opioid use disorders the most commonly prescribed (35.2% of neonates with NAS), while opioid PDD used in the treatment of pain contributed to 5.2% of NAS cases. Non-opioid PDD contributed to 1.7% of cases of NAS. The incidence of NAS associated with the use of opioids used to treat opioid use disorders (OUD) decreased over the study period (APC: -6.5, 95%CI: -9.5, -3.4), while NAS associated with opioids used to treat pain remained stable (APC: -2.7, 95%CI: -7.1, 1.9). CONCLUSION: The incidence of neonatal abstinence syndrome in WA remained stable from 2003 to 2018. Medications used to treat opioid use disorders were a substantial driver of NAS, although NAS associated with these medications has declined over time.
引用
- Kelty EA, Cumming CN, Preen DB, et al. Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018. Pharmacotherapy. 2022. PMID: 35342965. doi:10.1002/phar.2678
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。